1. Home
  2. NAT vs CTMX Comparison

NAT vs CTMX Comparison

Compare NAT & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nordic American Tankers Limited

NAT

Nordic American Tankers Limited

HOLD

Current Price

$5.42

Market Cap

1.2B

ML Signal

HOLD

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$3.76

Market Cap

977.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAT
CTMX
Founded
1995
2008
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
977.1M
IPO Year
1997
2015

Fundamental Metrics

Financial Performance
Metric
NAT
CTMX
Price
$5.42
$3.76
Analyst Decision
Sell
Strong Buy
Analyst Count
2
10
Target Price
$4.00
$12.10
AVG Volume (30 Days)
2.9M
2.8M
Earning Date
05-28-2026
05-08-2026
Dividend Yield
8.50%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$76,201,000.00
Revenue This Year
$77.72
N/A
Revenue Next Year
N/A
$7.61
P/E Ratio
$525.49
$22.58
Revenue Growth
N/A
N/A
52 Week Low
$2.55
$1.72
52 Week High
$6.34
$8.21

Technical Indicators

Market Signals
Indicator
NAT
CTMX
Relative Strength Index (RSI) 41.39 39.49
Support Level $5.39 $3.39
Resistance Level $6.30 $3.91
Average True Range (ATR) 0.19 0.20
MACD -0.04 0.00
Stochastic Oscillator 16.34 39.76

Price Performance

Historical Comparison
NAT
CTMX

About NAT Nordic American Tankers Limited

Nordic American Tankers Ltd owns and operates double-hull crude oil tankers. It is an international tanker company that owns double-hull Suezmax tankers. It operates vessels in the spot market or on spot market-related charters according to cooperative arrangements with third parties. The company's fleet consists of crude oil tankers, and all of its vessels are employed in the spot market. The company has only one type of vessel - Suezmax crude oil tankers. It operates in markets that are very competitive and based mainly on supply and demand.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: